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a b s t r a c t
Reactions of 0.5 eq. of the dinuclear complexes [(g6-arene)Ru(l-Cl)Cl]2 (arene =g6-C6H6, g6-p-iPrC6H4Me)
and [(Cp*)M(l-Cl)Cl]2 (M = Rh, Ir; Cp* = g5-C5Me5) with 4,6-disubstituted pyrazolyl-pyrimidine ligands
(L) viz. 4,6-bis(pyrazolyl)pyrimidine (L1), 4,6-bis(3-methyl-pyrazolyl)pyrimidine (L2), 4,6-bis(3,5-
dimethyl-pyrazolyl)pyrimidine (L3) lead to the formation of the cationic mononuclear complexes [(g6-
C6H6)Ru(L)Cl]+ (L = L1, 1; L2, 2; L3, 3), [(g6-p-iPrC6H4Me)Ru(L)Cl]+ (L = L1, 4; L2, 5; L3, 6), [(Cp*)Rh(L)Cl]+
(L = L1, 7; L2, 8; L3, 9) and [(Cp*)Ir(L)Cl]+ (L = L1, 10; L2, 11; L3, 12), while reactions with 1.0 eq. of the
dinuclear complexes [(g6-arene)Ru(l-Cl)Cl]2 and [(Cp*)M(l-Cl)Cl]2 give rise to the dicationic dinuclear
complexes [{(g6-C6H6)RuCl}2(L)]2+ (L = L1, 13; L2, 14; L3, 15), [{(g6-p-iPrC6H4Me)RuCl}2(L)]2+ (L = L1,
16; L2, 17; L3, 18), [{(Cp*)RhCl}2(L)]2+ (L = L1, 19; L2, 20; L3, 21) and [{(Cp*)IrCl}2(L)]2+ (L = L1 22; L2,
23; L3 24). The molecular structures of [3]PF6, [6]PF6, [7]PF6 and [18](PF6)2 have been established by sin-
gle crystal X-ray structure analysis.
1. Introduction
During the last few decades there has been great interest in the
chemistry of transition metals associated with polydentate ligands
with sp2-hybridized nitrogen atoms, for instance, polypyrazolylb-
orates [1,2] and polypyridines [2–10]. In many cases the charge
transfer properties of these compounds justify this interest.
Especially with these nitrogen donor ligands have been shown to
be effective catalysts for oxidation reactions [11–19] and for ring-
openingmetathesis polymerization [20] and recent studies of arene
ruthenium complexes have shown that they are found to inhibit
cancer cell growth [21–26], as non-linear optical (NLO) materials
[27,28]. For a majority of the complexes studied, the metal centers
are linked by a bridging ligand and the nature of the bridge has a
fundamental inﬂuence on the electronic interaction between the
metals and therefore on the characteristics of the material.
The ligand 4,6-bis(pyrazolyl)pyrimidine (L1) and its analogues,
4,6-bis(3-methyl-pyrazolyl)pyrimidine (L2) and 4,6-bis(3,5-
dimethyl-pyrazolyl)pyrimidine (L3), are the subject of this investi-
gation. They have a structural similarity to 3,6-bis(pyrazolyl)pyrid-
azine (A) and 4,5-bis(pyrazolyl)quinoxaline (B) both of which have
been previously studied [29,30]. In our previous work, we
demonstrated that the ligand A does not yield dinuclear com-
pounds with two half-sandwich platinum groupmetal atoms, since
the steric nature of the ligand, resulted only in the formation of
mononuclear complexes [29]. However it is true in the case of
more sterically free ligand B also, because it also yielded mononu-
clear complexes, since the pyrazole rings of the ligand tilted with
respect to the central quinoxaline ring because of the steric collide
between the R’ groups of the pyrazole rings. In the case of ligand A
the pyrazolyl rings are bonded para to each other, where as in the
case of ligand B, they are bonded ortho to each other on central six
membered rings. But sterically less demanding ligand L (L1–L3)
can coordinate to two half-sandwich platinum group metal cen-
ters, since the pyrazolyl rings of the ligand are bondedmeta to each
other, leading to reduced steric interaction, which enhances the
stability of the dinuclear complexes.
In recent years, we have been carrying out arene ruthenium
complexation reactions with a variety of nitrogen-based ligands
[31–36] including pyridyl-pyridazine and pyrazolyl-pyridazine
ligands. Ruthenium complexes of these types of nitrogen-based
ligands have a capacity to function as catalysts for the oxidation
of water to oxygen [37–39]. Although extensive studies have been
made on ruthenium complexes containing polypyridyl ligands,
complexes containing pyrazolyl-pyrimidine ligands have not yet
been investigated.
In the present paper, we focus on the synthetic methodology
applied for the development of homogeneous and immobilized
half-sandwich ruthenium, rhodium and iridium complexes bearing
bis(pyrazolyl)pyrimidine, as a speciﬁc N,N-bidentate bridging
ligands (L) (Scheme 1).
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All solvents were dried and distilled prior to use. 3-methylpyr-
azole, 3,5-dimethylpyrazole and 4,6-dichloropyrimidine (Aldrich)
were purchased and used as received. [(g6-C6H6)Ru(l-Cl)Cl]2,
[(g6-p-iPrC6H4Me)Ru(l-Cl)Cl]2 [40–42], and [(Cp*)M(l-Cl)Cl]2
(M = Rh, Ir) [43–45] were prepared according to literature meth-
ods. The preparation of ligand 4,6-bis(pyrazolyl)pyrimidine (L1)
has been previously described [46] and ligand 4,6-bis(3,5-di-
methyl-pyrazolyl)pyrimidine (L3) was prepared by the modiﬁed
procedure of Oro et al. [47]. 1H NMR spectra were recorded on Bru-
ker AMX-400 MHz spectrometer. Infrared spectra were recorded as
KBr pellets on a Perkin–Elmer 983 spectrophotometer; elemental
analyses of the complexes were performed on a Perkin–Elmer-
2400 CHN/S analyzer. Mass spectra were obtained from Waters
ZQ 4000 mass spectrometer by ESI method. Absorption spectra
were obtained at room temperature using a Perkin–Elmer Lambda
25 UV–Vis spectrophotometer.
2.2. Single crystal X-ray structure analyses
Crystals suitable for X-ray diffraction study for compounds
[3]PF6, [6]PF6, [7]PF6 and [18](PF6)2 were grown by slow diffusion
of diethylether/hexane into dichloromethane/acetone solution of
complexes [3]PF6H2O, [6]PF6, [7]PF6 and [18](PF6)2H2O, respec-
tively. The crystals were mounted on a Stoe Image Plate Diffraction
system equipped with a / circle goniometer, using Mo Ka graphite
monochromated radiation (k = 0.71073 Å) with / range 0–200.
The structures were solved by direct methods using the program
SHELXS–97 [48]. Reﬁnement and all further calculations were carried
out using SHELXL–97 [49]. The H-atoms were included in calculated
positions and treated as riding atoms using the SHELXL default
parameters. The non-H atoms were reﬁned anisotropically, using
weighted full-matrix least-square on F2. Crystallographic details
are summarized in Table 1 and selected bond lengths and angles
are presented in Table 2. Figs. 1–4 were drawn with ORTEP [50]
and Fig. 5 with the software MERCURY [51,52].
2.3. Preparation of ligands (L2 and L3)
2.3.1. 4,6-Bis(3-methyl-pyrazolyl)pyrimidine (L2)
To a solution of 3-methylpyrazole (1.20 g, 14.7 mmol) in 50 ml
of THF was added ﬁne pieces of potassium (0.600 g, 15.3 mmol),
the mixture was reﬂuxed at 50 C until the potassium was com-
pletely dissolved. Then 4,6-dichloropyrimidine (1.094 g,
7.35 mmol) was added to the reaction mixture(pale-brown solu-
tion), which was reﬂuxed for 5 h. Then 80 ml of water was added
and the solution refrigerated overnight. The colorless solid was ﬁl-
tered and washed with water (2  10 ml) and dried under P2O5.
The pure compound was obtained after recrystallization from chlo-
roform/hexane.
Yield: 0.72 g, 57.8%.
Elemental Anal. Calc. for C12H12N6: C, 59.99; H, 5.03; N, 34.98.
Found: C, 59.63; H, 5.18; N, 34.72%. 1H NMR (400 MHz, CDCl3):
d = 8.71 (s, 1H), 8.45 (d, 2H, 3J = 2.4 Hz), 8.29 (s, 1H), 6.29 (d, 2H,
3J = 2.4 Hz), 2.39 (s, 6H, CH3); ESI-MS (m/z): 241.11 [M+H]+; IR
(KBr, cm1): 2924m, 1597s, 1464m, 1382m, 1211m, 1044s, 777s.
2.3.2. 4,6-Bis(3,5-dimethyl-pyrazolyl)pyrimidine (L3)
The L3 ligand was synthesized in a similar manner using 3,5-
dimethylpyrazole (1.50 g, 15.6 mmol), potassium (0.60 g,
15.0 mmol) and 4,6-dichloropyrimidine (1.10 g, 7.35 mmol). How-
ever, after reﬂuxing the THF solution for 5 h, the mixture was evap-
orated to dryness. The product was extracted three times with
30 ml of toluene. The solvent was removed, and the white solid ob-
tained was dissolved in dichloromethane layering the resulting
solution with hexane led to the precipitation of traces of pyrazole.
L3 was obtained after ﬁltration and evaporation to dryness of the
resulting solution. The solid was recrystallized from chloroform/
hexane.
Yield: 1.5 g, 55%.
Elemental Anal. Calc. for C14H16N6: C, 62.67; H, 6.01; N, 31.32.
Found: C, 62.68; H, 6.05; N, 31.28%. 1H NMR (400 MHz, CDCl3):
d = 8.74 (s, 1H), 8.37 (s, 1H), 6.01 (s, 2H,), 2.67 (s, 6H, CH3), 2.29
(s, 6H, CH3); ESI-MS (m/z): 269.14 [M+H]+); IR (KBr, cm1):
3446w, 2925m, 1593s, 1484s, 1385m, 1266m, 1019s, 771m.
2.4. General procedure for the preparation of the mononuclear
complexes 1–6
A mixture of [(g6-C6H6)Ru(l-Cl)Cl]2 (arene = C6H6 and
p-iPrC6H4Me) (0.07 mmol), ligand L (L1, L2 or L3) (0.15 mmol)
and 2.5 equivalents of NH4PF6 in dry methanol (15 ml) was stirred
at room temperature for 8 h resulting in the precipitation of a dark
yellow solid. The precipitate was separated by ﬁltration, washed
with cold methanol, diethyl ether and dried in vacuo.
2.4.1. [(g6-C6H6)Ru(L1)Cl]PF6 ([1]PF6)
Yield: 66 mg, 82.5%.
Elemental Anal. Calc. for C16H14N6RuClPF6 (571.97): C, 33.61; H,
2.47; N, 14.70. Found: C, 33.73; H, 2.65; N, 13.98%. 1H NMR
(400 MHz, CDCl3): d = 9.56 (d, 1H, 3J = 2.4 Hz), 8.75 (d, 1H,
Scheme 1.
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3J = 2.4 Hz), 8.66 (d, 1H, 3J = 7.6 Hz), 8.63 (d, 1H, 3J = 7.6 Hz), 8.29 (s,
1H), 8.02 (s, 1H), 6.96 (dd, 1H, 3J = 2.0 Hz), 6.67 (dd, 1H, 3J = 1.6 Hz),
6.07 (s, 6H, C6H6); ESI-MS (m/z): 427.2 [MPF6]+, 392.1 [MPF6-
Cl]+, 314.1 [MPF6-Cl-C6H6]+; IR (KBr, cm1): 844s m(P–F), 1522m,
1558m, 1608s (mC@N L1), 2925m, 3446w; UV–Vis {acetonitrile, kmax
nm (e105M1 cm1)}: 246(0.16), 324(0.17), 381(0.25), 464(0.04).
2.4.2. [(g6-C6H6)Ru(L2)Cl] PF6 ([2]PF6)
Yield: 62 mg, 74.6%.
Elemental Anal. Calc. for C18H18N6RuClPF6 (599.86): C, 39.91; H,
3.35; N, 15.51. Found: C, 40.22; H, 3.08; N, 14.92%. 1H NMR
(400 MHz, CD3CN, 25 C, TMS): d = 9.15 (s, 1H), 8.54 (d, 1H,
3J = 8.4 Hz), 8.09 (s, 1H), 7.50 (d, 1H, 3J = 4.6 Hz), 7.21 (d, 1H,
3J = 4.6 Hz), 6.92 (d, 1H, 3J = 2.8 Hz), 6.24 (s, 6H, C6H6), 2.83 (s,
3H, CH3), 2.76 (s, 3H, CH3); ESI-MS (m/z): 455.2 [MPF6]+, 419.2
[MPF6-Cl]+, 341.1 [MPF6-Cl-C6H6]+; IR (KBr, cm1): 845s m(P–F),
1592m, 1558m, 1522m (mC@N L2), 2925m, 3434w; UV–Vis {aceto-
nitrile, kmax nm (e105M1 cm1)}: 319(0.23), 345(0.18), 456(0.04).
2.4.3. [(g6-C6H6)Ru(L3)Cl]PF6 ([3]PF6)
Yield: 65 mg, 86.3%.
Elemental Anal. Calc. for C20H22N6RuClPF6 (628.03): C, 42.16; H,
3.89; N, 14.75. Found: C, 41.90; H, 4.05; N, 14.33%. 1H NMR
(400 MHz, CD3CN): d = 9.44 (s, 1H), 8.17 (s, 1H), 7.39 (s, 1H), 6.53
(s, 1H), 6.10 (s, 6H, C6H6), 2.82 (s, 3H, CH3), 2.76 (s, 3H, CH3),
2.75 (s, 3H, CH3), 2.29 (s, 3H, CH3); ESI-MS (m/z): 483.3 [MPF6]+,
448.2 [MPF6-Cl]+, 413.3 [MPF6ClC6H6]+; IR (KBr, cm1): 845s
m(P–F), 1601m, 1560m, 1525m (mC@N L3), 2925m, 3482w; UV–Vis
{acetonitrile, kmax nm (e105M1 cm1)}: 273(0.15), 309(0.15),
354(0.25), 452(0.06).
2.4.4. [(g6-p-iPrC6H4Me)Ru(L1)Cl]PF6 ([4]PF6)
Yield: 65 mg, 75.5%.
Elemental Anal. Calc. for C20H22N6RuClPF6 (628.03): C, 38.26; H,
3.53; N, 13.38. Found: C, 37.92; H, 3.77; N, 12.95%. 1H NMR
(400 MHz, CDCl3): d = 9.48 (d, 1H, 3J = 2.4 Hz), 8.77 (d, 1H,
3J = 2.4 Hz, 1H), 8.67 (d, 1H, 3J = 4.6 Hz), 8.61 (d, 1H, 3J = 6.4 Hz),
8.29 (s, 1H), 7.97 (s, 1H), 6.96 (dd, 1H, 3J = 2.0 Hz), 6.69 (dd, 1H,
3J = 2.0 Hz), 6.04 (d, 1H, 3JH,H = 6.4 Hz, Arp-cy), 6.07 (d, 1H,
3J = 6.4 Hz, Arp-cy), 5.99 (d, 1H, 3J = 6.0 Hz, Arp-cy), 5.86 (d, 1H,
3J = 6.0 Hz, Arp-cy), 2.74 (sept, 1H, 3J = 6.2 Hz, CH(CH3)2), 2.18 (s,
3H, Arp-cy–Me), 1.14 (d, 3H, 3J = 6.4 Hz, CH(CH3)2), 1.10 (d, 3H,
3J = 7.6 Hz, CH(CH3)2); ESI-MS (m/z): 483.1 [MPF6]+, 448.1
[MPF6-Cl]+, 314.1 [MPF6-Cl-p-iPrC6H4Me]+; IR (KBr, cm1)
844s m(P–F), 1605m, 1557m, 1523m (mC@N L1), 3058m, 3489w;
UV–Vis {acetonitrile, kmax nm (e105M1 cm1)}: 286(0.65)
333(0.21), 436(0.02).
2.4.5. [(g6-p-iPrC6H4Me)Ru(L2)Cl]PF6 ([5]PF6)
Yield: 68 mg, 73.4%.
Elemental Anal. Calc. for C22H26N6RuClPF6 (651.06): C, 43.28; H,
4.29; N, 13.77. Found: C, 43.78; H, 3.94; N, 13.92%. 1H NMR
(400 MHz, CDCl3): d = 9.25 (s, 1H), 8.48 (d, 1H, 3J = 2.4 Hz), 7.89
(s, 1H), 7.78 (d, 1H, 3J = 2.8 Hz), 6.70 (d, 1H, 3J = 9.6 Hz), 6.39 (d,
1H, 3J = 2.8 Hz), 5.98 (d, 2H, 3J = 6.0 Hz, Arp-cy), 5.90 (d, 1H,
3J = 6.0 Hz, Arp-cy), 5.86 (d, 1H, 3J = 6.0 Hz, Arp-cy), 2.81 (s, 3H, CH3),
2.75 (sept, 1H, CH(CH3)2), 2.38 (s, 3H, CH3), 2.18 (s, 3H, Arp-cy–
Me), 1.42 (d, 3H, 3J = 3.2 Hz, CH(CH3)2), 1.17 (d, 3H, 3J = 3.2 Hz,
Table 2
Selected bond lengths and angles for complexes [3]PF6H2O, [6]PF6, [7]PF6 and
[18](PF6)2H2O.
[3]PF6 [6]PF6 [7]PF6 [18](PF6)2
Distances (Å)
M1–Cl1 2.402(7) 2.388(8) 2.40(6) 2.393(1)
M2–Cl2 – – – 2.391(1)
M1–N1 2.076(2) 2.102(2) 2.106(2) 2.072(3)
M1–N3 2.092(2) 2.093(2) 2.138(2) 2.092(3)
M2–N4 – – – 2.092(3)
M2–N6 – – – 2.076(3)
M1–centroida 1.690 1.685 1.770 1.685
M2–centroida – – – 1.678
Angles ()
N1–M1–N3 75.33(7) 75.56(9) 75.34(8) 75.70(1)
N4–M2–N6 – – – 75.0(1)
N1–M1–Cl1 84.76(6) 87.51(7) 90.43(7) 82.86(3)
N4–M2–Cl2 – – – 84.26(9)
N3–M1–Cl1 84.09(6) 84.27(7) 84.73(6) 83.31(9)
N6–M2–Cl2 – – – 81.70(9)
a Calculated centroid-to-metal distances (g6-C6 or g5-C5 coordinated aromatic
ring).
Table 1
Details of the data collection and results of the structure reﬁnement parameters for complexes [3]PF6H2O, [6]PF6, [7]PF6 and [18](PF6)2H2O.
Complex [3]PF6H2O [6]PF6 [7]PF6 [18](PF6)2H2O
Chemical formula C20H22ClF6N6OPRu C24H30ClF6N6PRu C20H23ClF6N6PRh C34H46Cl2F12N6OP2Ru2
Formula weight 628.03 684.03 630.77 1117.75
Crystal system Triclinic Triclinic Triclinic Monoclinic
Space group P1 P1 P1 P 21/a
Crystal color and shape Orange blade Red block Red block Orange block
Crystal size (mm) 0.25  0.12  0.12 0.28  0.28  0.18 0.50  0.26  0.15 0.21  0.18  0.13
a (Å) 8.4350(11) 8.4928(10) 7.5841(6) 17.1745(13)
b (Å) 9.1359(12) 12.1384(14) 11.2581(10) 13.5980(8)
c (Å) 16.328(2) 14.1361(16) 14.7304(12) 17.6465(11)
a () 91.340(2) 99.418(2) 74.056(2) 90.00
b () 92.071(2) 90.677(2) 88.015(2) 90.062(8)
c () 105.129(2) 104.611(2) 88.408(2) 90.00
V (Å3) 1213.2(3) 1389.0(3) 1208.39(17) 4121.1(5)
Z 2 2 2 4
T (K) 203(2) 203(2) 203(2) 173(2)
Dx (g /cm3) 1.763 1.636 1.734 1.802
l (mm1) 0.895 0.785 0.952 1.033
Scan range () 2.31 < h < 28.31 1.76 < h < 32.38 1.88 < h < 32.33 1.91 < h < 26.08
Unique reﬂections 12 483 17 438 14 825 8096
Reﬂections used [I > 2r(I)] 5998 9027 7813 5203
Rint 0.0260 0.0383 0.0244 0.0644
Final R indices [I > 2r(I)] 0.0385, wR2 0.1160 0.0513, wR2 0.1368 0.0428, wR2 = 0.1387 0.0379, wR2 = 0.0791
R indices (all data) 0.0415, wR2 0.1203 0.0615, wR2 0.1471 0.0463, wR2 = 0.1437 0.0700, wR2 = 0.0862
Goodness-of-ﬁt (GOF) 1.186 1.121 1.178 0.849
Maximum, Minimum Dq (e Å3) 1.183, 0.564 1.128, 0.754 1.214, 1.051 0.949, 0.807
3
CH(CH3)2); ESI-MS (m/z): 513.2 [MPF6]+, 478.6 [MPF6-Cl]+, 344.2
[MPF6-Cl-p-iPrC6H4Me]+; IR (KBr, cm1): 843s m(P–F), 1606m,
1560m, 1524m (mC@N L2), 2995m, 3447w; UV–Vis {acetonitrile, kmax
nm (e105M1 cm1)}: 294(0.36), 349(0.82), 470(0.02).
2.4.6. [(g6-p-iPrC6H4Me)Ru(L3)Cl]PF6 ([6]PF6)
Yield: 77 mg, 82.7%.
Elemental Anal. Calc. for C24H30N6RuClPF6 (684.09): C, 46.06; H,
4.83; N, 13.43. Found: C, 46.73; H, 4.25; N, 13.07%. 1H NMR
(400 MHz, CDCl3): d = 9.44 (s, 1H), 8.11 (s, 1H), 7.32 (s, 1H), 7.05
(s, 1H), 5.96 (d, 1H, 3J = 4.0 Hz, Arp-cy), 5.92 (d, 1H, 3J = 3.2 Hz,
Arp-cy), 5.84 (d, 1H, 3J = 6.4 Hz, Arp-cy), 5.77 (d, 1H, 3J = 6.4 Hz,
Arp-cy), 2.81 (s, 3H, CH3), 2.79 (s, 3H, CH3), 2.81 (s, 3H, CH3), 2.78
(s, 3H, CH3), 2.49 (sept, 1H, CH(CH3)2), 2.17 (s, 3H, Arp-cy–Me),
1.09 (d, 3H, 3J = 3.2 Hz, CH(CH3)2), 1.06 (d, 3H, 3J = 3.2 Hz,
CH(CH3)2); ESI-MS (m/z): 538.8 [MPF6]+, 503.5 [MPF6-Cl]+,
369.2 [MPF6-Cl-p-iPrC6H4Me]+; IR (KBr, cm1): 843s m(P–F),
1608m, 1560m, 1527m (mC@N L3), 3050m, 3447w; UV–Vis {aceto-
nitrile, kmax nm (e105M1 cm1)}: 287(0.38), 346(0.74), 477(0.08).
2.5. General procedure for the preparation of the mononuclear
complexes 7–12
A mixture of [(g5-C5Me5)M(l-Cl)Cl]2 (M = Rh and Ir)
(0.08 mmol), ligand L (L1, L2 and L3) (0.17 mmol) and 2.5 equiva-
lents of NH4PF6 in dry methanol (20 ml) was reﬂuxed at 50 C tem-
perature for 4–6 h, resulting yellow color precipitation. The
precipitate was separated by ﬁltration, washed with cold metha-
nol, diethyl ether and dried in vacuo.
2.5.1. [(Cp*)Rh(L1)Cl]PF6 ([7]PF6)
Yield: 73 mg, 77.8%.
Elemental Anal. Calc. for C20H23N6RhClPF6 (630.04): C, 38.08; H,
3.68; N, 13.98. Found: C, 38.13; H, 3.75; N, 13.91%. 1H NMR
(400 MHz, CD3CN): d = 9.01 (s, 1H), 8.84 (d, 1H, 3J = 3.2 Hz), 8.66
(d, 1H, 3J = 2.4 Hz), 8.33 (d, 1H, 3J = 1.6 Hz), 8.31 (d, 1H,
3J = 1.6 Hz), 7.98 (s, 1H), 7.02 (dd, 1H, 3J = 1.6 Hz), 6.71 (dd, 1H,
3J = 1.6 Hz), 1.75 (s, 15H, C5Me5); ESI-MS (m/z): 485.2 [MPF6]+,
450.6 [MPF6-Cl]+, 315.2 [MPF6-Cl-Cp*]; IR (KBr, cm1): 844s
m(P–F), 1606m, 1560m, 1524m (mC@N L1), 2999m, 3448w; UV–Vis
{acetonitrile, kmax nm (e105M1 cm1)}: 268(0.78), 286(0.76),
357(0. 4), 444(0.09).
2.5.2. [(Cp*)Rh(L2)Cl]PF6 ([8]PF6)
Yield: 65 mg, 62.5%.
Elemental Anal. Calc. for C22H27N6RhClPF6 (658.07): C, 35.32; H,
3.64; N, 11.23. Found: C, 35.26; H, 3.69; N, 11.21%. 1H NMR
(400 MHz, CD3CN): d = 8.78 (s, 1H), 8.43 (d, 1H, 3J = 6.4 Hz), 8.09
(s, 1H), 6.76 (d, 1H, 3J = 4.6 Hz), 6.40 (d, 1H, 3J = 4.6 Hz), 6.32 (d,
1H, 3J = 2.8 Hz), 2.70 (s, 3H, CH3), 2.43 (s, 3H, CH3), 1.77 (s, 15H,
C5Me5); ESI-MS (m/z): 513.8 [MPF6]+, 478.12 [MPF6-Cl]+, 343.2
[MPF6-Cl-Cp*]; IR (KBr, cm1): 845s m(P–F), 1598m, 1559m,
1521m (mC@N L2), 2995m, 3447w; UV–Vis {acetonitrile, kmax nm
(e105M1 cm1)}: 266(0.54), 301(0.45), 343(0.57), 452(0.07).
2.5.3. [(Cp*)Rh(L3)Cl]PF6 ([9]PF6)
Yield: 78 mg, 72%.
Elemental Anal. Calc. for C24H31N6RhClPF6 (686.87): C, 41.97; H,
4.55; N, 12.24. Found: C, 41.86; H, 4.65; N, 12.18%. 1H NMR
(400 MHz, CD3CN): d = 9.05 (s, 1H), 8.67 (s, 1H), 7.40 (s, 1H), 6.66
(s, 1H), 2.82 (s, 3H, CH3), 2.76 (s, 3H, CH3), 2.75 (s, 3H, CH3), 2.29
(s, 3H, CH3), 2.01 (s, 15H, C5Me5); ESI-MS (m/z): 541.81 [MPF6]+,
506.6 [MPF6-Cl]+, 371.2 [MPF6-Cl-Cp*]; IR (KBr, cm1): 843s
m(P–F), 1601m, 1557m, 1524m (mC@N L3), 3050m, 3434w; UV–Vis
{acetonitrile, kmax nm (e105M1 cm1)}: 261(0.09), 314(0.61),
441(0.05).
2.5.4. [(Cp*)Ir(L1)Cl]PF6 ([10]PF6)
Yield: 66 mg, 58.4%.
Elemental Anal. Calc. for C20H23N6IrClPF6 (720.09): C, 33.61; H,
2.47; N, 14.70. Found: C, 33.73; H, 2.65; N, 13.98%. 1H NMR
(400 MHz, CD3CN): d = 8.99 (s, 1H), 8.84 (d, 1H, 3J = 3.2 Hz), 8.66
(d, 1H, 3J = 2.4 Hz), 8.39 (d, 1H, 3JH,H = 1.6 Hz), 8.32 (d, 1H,
3JH,H = 1.6 Hz), 7.98 (s, 1H), 7.01 (dd, 1H, 3JH,H = 1.6 Hz), 6.70 (dd,
1H, 3JH,H = 2.0 Hz), 2.01 (s, 15H, C5Me5); ESI-MS (m/z): 575.2
[MPF6]+, 535.6 [MPF6-Cl]+, 400.2 [MPF6-Cl-Cp*]; IR (KBr,
cm1): 845s m(P–F), 1592m, 1558m, 1522m (mC@N L1) 2924m,
3439w; UV–Vis {acetonitrile, kmax nm (e105M1 cm1)}:
279(0.53), 340(0.89), 402(0.20).
2.5.5. [(Cp*)Ir(L2)Cl]PF6 ([11]PF6)
Yield: 70 mg, 57.8%.
Elemental Anal. Calc. for C22H27N6IrClPF6 (748.13): C, 35.32; H,
3.64; N, 11.23. Found: C, 35.25; H, 3.68; N, 11.22%. 1H NMR
(400 MHz, CD3CN): d = 8.78 (s, 1H), 8.43 (d, 1H, 3J = 6.4 Hz), 8.09
(s, 1H), 6.76 (d, 1H, 3J = 4.6 Hz), 6.40 (d, 1H, 3J = 4.6 Hz), 6.32 (d,
1H, 3J = 2.8 Hz), 2.70 (s, 3H, CH3), 2.43 (s, 3H, CH3), 1.77 (s, 15H,
C5Me5); ESI-MS (m/z): 603.1 [MPF6]+, 568.2 [MPF6-Cl]+, 433.2
[MPF6-Cl-Cp*]; IR (KBr, cm1): 845s m(P–F), 1598m, 1559m,
1521m (mC@N L2), 2995m, 3446w; UV–Vis {acetonitrile, kmax nm
(e105M1 cm1)}: 267(0.54), 298(0.82), 429(0.08).
2.5.6. [(Cp*)Ir(L3)Cl]PF6 ([12]PF6)
Yield: 78 mg, 64.4%.
Elemental Anal. Calc. for C24H31N6IrClPF6 (776.96): C, 37.14; H,
4.03; N, 10.83. Found: C, 37.06; H, 4.05; N, 10.33%. 1H NMR
(400 MHz, CD3CN): d = 8.90 (s, 1H), 8.21 (s, 1H), 6.67 (s, 1H), 6.20
(s, 1H), 2.83 (s, 3H, CH3), 2.76 (s, 3H, CH3), 2.64 (s, 3H, CH3), 2.30
(s, 3H, CH3), 2.15 (s, 15H, C5Me5); ESI-MS (m/z): 631.2 [MPF6]+,
596.6 [MPF6-Cl]+, 461.2 [MPF6-Cl-Cp*]; IR (KBr, cm1): 843s
m(P–F), 1606m, 1560m, 1524m (mC@N L2), 3050m, 3446w; UV–Vis
{acetonitrile, kmax nm (e105M1 cm1)}: 268(0.50), 301(0.41),
361(0.51) and 464(0.04).
2.6. General procedure for the preparation of the dinuclear complexes
13–18
A mixture of [(g6-arene)Ru(l-Cl)Cl]2 (arene = C6H6 and g6-
p-iPrC6H4Me) (0.1 mmol), ligand L (L1, L2 and L3) (0.1 mmol) and
2.5 equivalents of NH4PF6 in dry methanol (15 ml) was stirred at
room temperature for 14 h resulting orange color precipitation.
The precipitate was ﬁltered, washed with cold methanol, diethyl
ether and dried in vacuo.
2.6.1. [{(g6-C6H6)RuCl}2(L1)](PF6)2 ([13](PF6)2)
Yield: 72 mg, 77.4%.
Elemental Anal. Calc. for C22H20N6Ru2Cl2P2F12 (931.41): C,
28.37; H, 2.16; N, 9.02. Found: C, 38.21; H, 2.45; N, 8.98%. 1H
NMR (400 MHz, CD3CN): d = 9.68 (d, 2H, 3J = 2.8 Hz), 8.79 (s, 1H),
8.71 (d, 2H, 3J = 7.2 Hz), 8.32 (s, 1H), 7.01 (dd, 2H, 3J = 2.0 Hz),
6.15 (s, 12H, C6H6);. ESI-MS (m/z): 786.1 [M2++PF6]+, 427.2
[MPF6]+; IR (KBr, cm1): 845s m(P–F), 1598m, 1559m, 1521m (mC@N
L1), 2995m, 3447w; UV–Vis {acetonitrile, kmax nm (e105M1
cm1)}: 259(0.21), 318(0.23), 380(0.08).
2.6.2. [{(g6-C6H6)RuCl}2(L2)](PF6)2 ([14](PF6)2)
Yield: 71 mg, 74.7%.
Elemental Anal. Calc. for C24H24N6Ru2Cl2P2F12 (959.46): C,
30.04; H, 2.52; N, 8.76. Found: C, 29.95; H, 2.58; N, 8.61%. 1H
NMR (400 MHz, CD3CN): d = 9.46 (s, 1H), 8.58 (d, 2H, 3J = 8.4 Hz),
8.15 (s, 1H), 7.25 (d, 2H, 3J = 4.6 Hz), 6.24 (s, 12H, C6H6), 2.83 (s,
3H,CH3), 2.81 (s, 3H, CH3); ESI-MS (m/z):814.2 [M2++PF6]+, 455.2
[MPF6]+; IR (KBr, cm1): 843s m(P–F), 1601m, 1557m, 1524m (mC@N
4
L2), 3010m, 3449w; UV–Vis {acetonitrile, kmax nm (e105M1
cm1)}: 262(0.29), 310(0.75), 374(0.12).
2.6.3. [{(g6-C6H6)RuCl}2(L3)](PF6)2 ([15](PF6)2)
Yield: 81 mg, 82.6%.
Elemental Anal. Calc. for C24H28N6Ru2Cl2P2F12 (987.52): C,
31.62; H, 2.86; N, 8.51. Found: C, 31.50; H, 2.95; N, 8.33%. 1H
NMR (400 MHz, CD3CN): d = 10.02 (s, 1H), 7.68 (s, 1H), 6.72 (s,
2H), 6.21 (s, 12H, C6H6), 2.81 (s, 6H, CH3), 2.69 (s, 6H, CH3); ESI-
MS (m/z): 842.4 [M2++PF6]+, 483.3 [MPF6]+; IR (KBr, cm1):
843s m(P–F), 1606m, 1560m, 1524m (mC@N L3), 3050m, 3451w;
UV–Vis {acetonitrile, kmax nm (e105M1 cm1)}: 271(0.18),
315(0.81), 380(0.11).
2.6.4. [{(g6-p-iPrC6H4Me)RuCl}2(L1)](PF6)2 ([16](PF6)2)
Yield: 87 mg, 83.6%.
Elemental Anal. Calc. for C30H36N6Ru2Cl2P2F12 (1043.62): C,
34.53; H, 3.48; N, 8.05. Found: C, 34.42; H, 3.47; N, 7.96%. 1H
NMR (400 MHz, CDCl3): d = 9.65 (d, 2H, 3J = 2.4 Hz), 8.71 (d, 2H,
3J = 4.6 Hz), 8.68 (s, 1H), 7.28 (s, 1H), 7.06 (dd, 2H, 3J = 2.4 Hz),
6.08 (d, 2H, 3J = 6.4 Hz, Arp-cy), 6.06 (d, 2H, 3J = 6.4 Hz, Arp-cy),
5.99 (d, 2H, 3J = 6.0 Hz, Arp-cy), 5.93 (d, 2H, 3J = 6.0 Hz, Arp-cy),
2.74–2.69 (sept, 2H, 3J = 6.2 Hz, CH(CH3)2), 2.18 (s, 6H, Arp-cy–
Me), 1.14 (d, 6H, 3J = 6.8 Hz, CH(CH3)2), 1.04 (d, 6H, 3J = 7.6 Hz,
CH(CH3)2); ESI-MS (m/z): 898.2 [M2++PF6]+, 483.3 [MPF6]+; IR
(KBr, cm1): 844s m(P–F), 1599m, 1560m, 1525m (mC@N L1),
2995m, 3447w; UV–Vis {acetonitrile, kmax nm (e105M1 cm1)}:
260(0.29), 310(0.58), 378(0.13).
2.6.5. [{(g6-p-iPrC6H4Me)RuCl}2(L2)](PF6)2 ([17](PF6)2)
Yield: 77 mg, 71.9%.
Elemental Anal. Calc. for C32H40N6Ru2Cl2P2F12 (1071.67): C,
35.86; H, 3.76; N, 7.84. Found: C, 43.78; H, 3.94; N, 13.92%. 1H
NMR (400 MHz, CDCl3): d = 9.38 (s, 1H), 8.51 (d, 2H, 3J = 2.8 Hz),
7.89 (s, 1H), 6.75 (d, 2H, 3J = 9.6 Hz), 6.01 (d, 2H, 3J = 6.0 Hz, Arp-cy),
5.99 (d, 2H, 3J = 6.04 Hz, Arp-cy), 5.96 (d, 2H, 3J = 6.0 Hz, Arp-cy),
5.96 (d, 2H, 3J = 6.04 Hz, Arp-cy), 2.81 (s, 6H, CH3), 2.75 (sept, 2H,
CH(CH3)2), 2.26 (s, 6H, Arp-cy–Me), 1.19 (d, 6H, 3J = 3.2 Hz,
CH(CH3)2), 1.17 (d, 6H, 3J = 3.2 Hz, CH(CH3)2); ESI-MS (m/z): 926.2
[M2++PF6]+, 513.2 [MPF6]+; IR (KBr, cm1): 843s m(P–F), 1601m,
1557m, 1524m (mC@N L2), 3011m, 3451w; UV–Vis {acetonitrile,
kmax nm (e105M1 cm1)}: 271(0.18), 315(0.81), 380(0.11).
2.6.6. [{(g6-p-iPrC6H4Me)RuCl}2(L3)](PF6)2 ([18](PF6)2)
Yield: 90 mg, 82.5%.
Elemental Anal. Calc. for C34H44N6Ru2Cl2P2F12 (1099.73): C,
37.13; H, 4.03; N, 7.64. Found: C, 37.05; H, 4.07; N, 7.64. 1H NMR
(400 MHz, CDCl3): d = 9.91 (s, 1H), 7.67 (s, 1H), 6.68 (s, 2H), 6.11
(d, 2H, 3J = 6.4 Hz, Arp-cy), 6.08 (d, 2H, 3J = 6.2 Hz, Arp-cy), 5.95 (d,
2H, 3J = 6.0 Hz, Arp-cy), 5.89 (d, 2H, 3J = 6.4 Hz, Arp-cy), 2.80 (s, 6H,
CH3), 2.76 (s, 6H, CH3), 2.66 (sept, 2H, CH(CH3)2), 2.28 (s, 6H, Arp-
cy–Me), 1.09 (d, 6H, 3J = 3.2 Hz, CH(CH3)2), 1.06 (d, 6H, 3J = 3.2 Hz,
CH(CH3)2); ESI-MS (m/z): 954.73 [M2++PF6]+, 538.8 [MPF6]+; IR
(KBr, cm1): 843s m(P–F), 1608m, 1562m, 1524m (mC@N L3),
3041m, 3447w; UV–Vis {acetonitrile, kmax nm (e105M1 cm1)}:
263(0.29), 310(0.75), 376(0.12).
2.7. General procedure for the preparation of the dinuclear complexes
19–24
A mixture of [(Cp*)M(l-Cl)Cl]2 (M = Rh and Ir) (0.08 mmol), li-
gand L (L1, L2 and L3) (0.08 mmol) and 2.5 equivalents of NH4PF6
in dry methanol (20 ml) was reﬂuxed at 50 C for 12 h, resulting
a orange color precipitation. The precipitate was separated by ﬁl-
tration, washed with cold methanol, diethyl ether and dried in
vacuo.
2.7.1. [(Cp*)RhCl}2(L1)](PF6)2 ([19](PF6)2)
Yield: 66 mg, 79.5%.
Elemental Anal. Calc. for C30H38N6Rh2Cl2P2F12 (1049.31): C,
34.34; H, 3.65; N, 8.01. Found: C, 34.23; H, 3.75; N, 7.91%. 1H
NMR (400 MHz, CD3CN): d = 9.18 (s, 1H), 8.84 (d, 2H, 3J = 3.2 Hz),
8.36 (d, 2H, 3J = 1.6 Hz), 8.01 (s, 1H), 6.92 (dd, 2H, 3J = 1.6 Hz),
1.81 (s, 30H, C5Me5); ESI-MS (m/z): 904.3 [M2++PF6]+, 485.2
[MPF6]+; IR (KBr, cm1): 845s m(P–F), 1592m, 1558m, 1522m (mC@N
L1), 2995m, 3447w; UV–Vis {acetonitrile, kmax nm (e105M1
cm1)}: 271(0.18), 315(0.81), 380(0.11).
2.7.2. [(Cp*)RhCl}2(L2)](PF6)2 ([20](PF6)2)
Yield: 60 mg, 70.5%.
Elemental Anal. Calc. for C32H42N6Rh2Cl2P2F12 (1077.36): C,
35.67; H, 3.93; N, 7.80. Found: C, 35.26; H, 3.99; N, 7.61%. 1H
NMR (400 MHz, CD3CN): d = 9.05 (s, 1H), 8.46 (d, 2H, 3J = 6.0 Hz),
8.12 (s, 1H), 6.79 (d, 2H, 3J = 4.6 Hz), 2.76 (s, 3H, CH3), 2.73 (s,
3H, CH3), 1.77 (s, 30H, C5Me5); ESI-MS (m/z):513.8 [MPF6],
932.1 [M2++PF6]+, 513.8 [MPF6]+; IR (KBr, cm1): 845s m(P–F),
1598m, 1559m, 1521m (mC@N L2), 2998m, 3449w; UV–Vis {aceto-
nitrile, kmax nm (e105M1 cm1)}: 259(0.11), 315(0.51), 380(0.08).
2.7.3. [(Cp*)RhCl}2(L3)](PF6)2 ([21](PF6)2)
Yield: 67 mg, 77.1%.
Elemental Anal. Calc. for C34H46N6Rh2Cl2P2F12 (1105.41): C,
36.94; H, 4.19; N, 7.60. Found: C, 36.86; H, 4.15; N, 7.58%. 1H
NMR (400 MHz, CD3CN): d = 9.09 (s, 1H), 7.36 (s, 1H), 6.79 (s,
2H), 2.84 (s, 6H, CH3), 2.79 (s, 6H, CH3), 1.88 (s, 30H, C5Me5); ESI-
MS (m/z): 960.2 [M2++PF6]+, 541.81 [MPF6]+; IR (KBr, cm1):
843s m(P–F), 1601m, 1557m, 1524m (mC@N L3), 3010m, 3442w;
UV–Vis {acetonitrile, kmax nm (e105M1 cm1)}: 269(0.18),
315(0.48), 371(0.10).
2.7.4. [(Cp*)IrCl}2(L1)](PF6)2 ([22](PF6)2)
Yield: 72 mg, 75.7%.
Elemental Anal. Calc. for C30H38N6Ir2Cl2P2F12 (1227.93): C,
29.34; H, 3.12; N, 6.84. Found: C, 29.23; H, 3.15; N, 6.71%. 1H
NMR (400 MHz, CD3CN): d = 9.01 (s, 1H), 8.84 (d, 2H, 3J = 3.2 Hz),
8.41 (d, 2H, 3J = 2.4 Hz), 8.03 (s, 1H), 6.95 (dd, 2H, 3J = 1.6 Hz),
1.79 (s, 30H, C5Me5); ESI-MS (m/z): 1082.2 [M2++PF6]+, 575.2
[MPF6]+; IR (KBr, cm1): 845s m(P–F), 1598m, 1559m, 1521m (mC@N
L1), 2995m, 3447w; UV–Vis {acetonitrile, kmax nm (e105M1
cm1)}: 260(0.19), 310(0.67), 368(0.11).
2.7.5. [(Cp*)IrCl}2(L2)](PF6)2 ([23](PF6)2)
Yield: 60 mg, 61%.
Elemental Anal. Calc. for C32H42N6Ir2Cl2P2F12 (1255.98): C,
30.60; H, 3.37; N, 6.69. Found: C, 30.45; H, 3.48; N, 6.51%. 1H
NMR (400 MHz, CD3CN): d = 9.01 (s, 1H), 8.48 (d, 2H, 3J = 6.4 Hz),
8.15 (s, 1H), 6.71 (d, 2H, 3J = 4.6 Hz), 2.63 (s, 6H, CH3), 1.75 (s,
30H, C5Me5); ESI-MS (m/z):1111.1 [M2++PF6]+, 603.1 [MPF6]+;
IR (KBr, cm1): 844s m(P–F), 1599m, 1560m, 1525m (mC@N L2),
3002m, 3441w; UV–Vis {acetonitrile, kmax nm (e105M1 cm1)}:
265(0.16), 315(0.56), 371(0.09).
2.7.6. [(Cp*)IrCl}2(L3)](PF6)2 ([24](PF6)2)
Yield: 74 mg, 74%.
Elemental Anal. Calc. for C34H46N6Ir2Cl2P2F12 (1284.04): C,
31.80; H, 3.61; N, 6.54. Found: C, 31.76; H, 3.78; N, 6.33%. 1H
NMR (400 MHz, CD3CN): d = 9.04 (s, 1H), 7.31 (s, 1H), 6.68 (s,
2H), 2.83 (s, 6H, CH3), 2.79 (s, 6H, CH3), 1.82 (s, 30H, C5Me5); ESI-
MS (m/z): 1139.5 [M2++PF6]+, 631.2 [MPF6]+; IR (KBr, cm1):
843s m(P–F), 1608m, 1562m, 1524m (mC@N L3), 3016m, 3450w;
UV–Vis {acetonitrile, kmax nm (e105M1 cm1)}: 268(0.19),
321(0.61), 376(0.13).
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3. Results and discussion
3.1. Syntheses of ligands and complexes
Ligands L2 and L3 were prepared from the corresponding
pyrazolato anion and 4,6-dichloropyrimidine. Reaction of half
equivalent of dinuclear arene ruthenium complexes [(g6-arene)R-
u(l-Cl)Cl]2 (arene = C6H6, p-iPrC6H4Me) with one equivalent of 4,6-
disubstituted pyrimidine ligands viz. 4,6-bis(pyrazolyl)pyrimidine
(L1), 4,6-bis(3-methyl-pyrazolyl)pyrimidine (L2) or 4,6-bis(3,5-di-
methyl-pyrazolyl)pyrimidine (L3) in methanol generates the
mononuclear complexes [(g6-C6H6)Ru(L)Cl]+ (L = L1, 1; L2, 2; L3,
3), [(g6-p-iPrC6H4Me)Ru(L)Cl]+ (L = L1, 4; L2, 5; L3, 6), respectively
(Scheme 2). The homologous complexes with two coordinated
arene ruthenium fragments, [{(g6-C6H6)RuCl}2(L)](PF6)2 (L = L1,
13; L2, 14; L3, 15) and [{(g6-p-iPrC6H4Me)RuCl}2(L)] (PF6)2
(L = L1, 16; L2, 17; L3, 18), were prepared when a 1:1 M ratio
was used and over prolonged reaction times (Scheme 2). All these
cationic ruthenium complexes were isolated as their hexaﬂuoro-
phosphate salts.
Similarly, the reaction of half equivalent of the dimeric chloro-
bridged complexes [(Cp*)M(l-Cl)Cl]2 (M = Rh, Ir) with 4,6-disubsti-
tuted-pyrimidine ligands (L) inmethanol generates themononuclear
cationic complexes of the type [(Cp*)Rh(L)Cl]+ (L = L1, 7; L2, 8; L3, 9),
[(Cp*)Ir(L)Cl]+ (L = L1, 10; L2, 11; L3, 12), respectively (Scheme 3). The
homologous complexes with two coordinated Cp*Rh or Cp*Ir frag-
ments, [{(Cp*)RhCl}2(L)](PF6)2 (L = L1, 19; L2, 20; L3, 21) and
[{(Cp*)IrCl}2(L)](PF6)2 (L = L1, 22; L2, 23; L3, 24), were preparedwhen
a 1:1 M ratio was used and at prolonged reaction times (Scheme 3).
All these cationic rhodium or iridium complexes were isolated as
their hexaﬂuorophosphate salts.
When the mononuclear complexes [1]PF6 – [12]PF6 were fur-
ther reacted with half mole of arene ruthenium or Cp*Rh or Ir di-
mers in acetonitrile solution, no reaction took place and isolated
as starting compounds. Also attempts to synthesize hetero-nuclear
complexes by reaction of the mononuclear complexes with other
metal atoms led to no reaction.
All these complexes are orange yellow in color, non-hygro-
scopic, air stable solids. They are soluble in acetonitrile but par-
tially soluble in dichloromethane, chloroform and acetone.
3.2. Characterization of mononuclear complexes 1 – 12
All these mononuclear complexes were characterized by IR, 1H
NMR, mass and elemental analysis. The infrared spectra of the




844–850 cm1, a typical mP–F stretching band for the PF6 anions.
Moreover, all complexes show absorption bands around 1600–
1610 cm1, 1550–1558 cm1 and 1522–1528 cm1 corresponding
to mC@N vibrations of pyrazole and pyrimidine moieties [52] besides
these absorptions 2990–3050 and 3400–3450 were observed.
The mass spectra of these complexes exhibited, as expected, the
corresponding molecular ion peaks m/z at 427, 455, 483, 483, 511,
538, 485, 513, 541, 575, 603 and 631. For instance complex [1]PF6
shown four fragments, a molecular ion peak at 427 [M]+, 391
[MCl]+, 313 [MCl-arene]+ and 213 [L+1].
The 1H NMR spectra of the free ligands L1–L3 exhibit a charac-
teristic set of ﬁve resonances for the eight protons of pyrazole and
pyrimidine rings, since the pyrazole rings are in symmetrical posi-
tion. Upon coordination with the metal atom, each mononuclear
complex has shown seven to eight set of resonances for the ligand
L1–L3 protons in the region d = 9.56–6.78, d = 9.41–2.43, and d =
9.34–2.17, respectively. It indicates the formation of mononuclear
complexes. The resonances of the coordinated pyrazole and pyrim-
idine rings protons shifted to higher frequency as a consequence of
their coordination to the ruthenium or rhodium or iridium atom.
However, arene ruthenium complexes [1]PF6 – [6]PF6, the reso-
nances of ligand protons signiﬁcantly shifted to down ﬁeld com-
pared to Cp*Rh or Cp*Ir complexes, [7]PF6 – [12]PF6. Besides
these ligand resonances, complexes [1]PF6 – [3]PF6 exhibit a singlet
for the benzene ring protons at d = 6.20–5.93, complexes [4]PF6 to
[6]PF6 exhibit a septet at d = 2.70 for the protons of the isopropyl
group and a singlet at d = 2.17 for the methyl protons of the p-cym-
ene ring. The ring protons and methyl protons of the isopropyl
group of the p-cymene ligand have shown an unusual pattern of
resonances. For instance, the methyl protons of the isopropyl group
displays two doublets at ca. d = 1.18–1.07, instead of one doublet as
in the starting complex. The aromatic protons of the p-cymene li-
gand display four doublets, instead of two doublets as in the start-
ing precursor. This unusual pattern is due to the diastereotopic
methyl protons of the isopropyl group and aromatic protons of
the p-cymene ligand since the ruthenium atom is stereogenic
due to the coordination of four different ligand atoms [53,54].
Complexes [1]PF6 to [12]PF6 exhibit a singlet at d = 1.71–1.55 for
the ﬁve methyl groups of the Cp* ligand. The chemical shift of
the co-ligands arene or Cp* ring protons are shifted to down ﬁeld
compared to the starting precursors.
3.3. Molecular structure of selected mononuclear complexes
The molecular structure of the [(g6-C6H6)Ru(L3)Cl]PF6 ([3]PF6),
[(g6-p-iPrC6H4Me)Ru(L3)Cl]PF6 ([6]PF6) as well as the Cp* rhodium
complex [(Cp*)Rh(L1)Cl]PF6 ([7]PF6) have been established by sin-
gle crystal X-ray structure analysis. These cationic complexes show
a typical piano-stool geometry with the metal center being coordi-
nated by an aromatic ligand, a terminal chloro ligand and a chelat-
ing 4,6-disubstituted-pyrimidine ligand. The metal atom possesses
an octahedral arrangement with two cis-nitrogen atoms of the pyr-
azolyl-pyrimidine ligand acting as a bidentate chelating ligand in a
ﬁve-membered ring chelating fashion involving one nitrogen atom
of the pyrazolyl moiety and the nitrogen atom of the pyrimidine
group. The structures are shown in Figs. 1–3. Selected bond lengths
and angles for [3]PF6, [6]PF6 and [7]PF6 are presented in Table 2.
In the mononuclear complexes [3]PF6 and [7]PF6 the N1-metal
distance (2.076 and 2.106 Å) of the pyrazolyl moiety is slightly
shorter than the corresponding pyrimidinyl, N3-metal distance
(2.092, and 2.138 Å), in contrast to complex [6]PF6 in which the
N1-metal (2.102 Å) distance is slightly longer than the correspond-
ing N3-metal distance (2.093(2) Å). The Rh–N bond distance
(2.106(3) and 2.138(3) Å) in 7 is slightly longer than the corre-
sponding distances of ruthenium complex 3 (2.076(3) and
2.092(2) Å) and complex 6 (2.102 and 2.093), while the MCl
[2.402(7), 2.388(8) and 2.400(6)] bond lengths show no signiﬁcant
differences in all the cations and similar reported values [55,56].
The N–M–N bond angles [75.33(7) in 3 and 75.56(9) in 6] are sim-
ilar to that of complexes [(g6p-iPrC6H4Me)RuCl(2,3-bis(a-pyri-
dyl)quinoxaline)]+ [76.2 (2)] [57]. The distances between the
ruthenium atom and the centroid of the C6 aromatic ring in 3
and 6 are comparable (1.69 and 1.68 Å) but quite shorter
than the distance between the rhodium atom and the C5 aromatic
ring observed in 7 (1.77 Å). The M–N1 bond distances [2.076(9)
to 2.102(2) Å] are comparable to those in g6-p-iPrC6H4Me
Fig. 1. Molecular structure of [3]PF6H2O at 50% probability level. Hydrogen atoms,
water molecule and hexaﬂuorophosphate anion have been omitted for clarity.
Fig. 2. Molecular structure of [6]PF6 at 50% probability level. Hydrogen atoms and
hexaﬂuorophosphate anion have been omitted for clarity.
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[(g6-C6H6)RuCl(2-(1-imidazol-2-yl)pyridine)]+ [58] and [(Cp*)Ir(2-
(20-pyridyl)-imidazole)Cl]+ [59].
As ampliﬁed in Figs. 1–3, all cations possess metal-centered chi-
rality as the metal atom is coordinated to four different ligator
atoms. However, since none of the ligands contain chiral centers,
they are all obtained as a racemic mixture and they all crystallize
in the centrosymmetric space group P1.
In the crystal packing of [3]PF6H2O, the hexaﬂuorophosphate
anion sits on side of the cationic complex and interacts with an
hydrogen atom of the C6H6 ligand (see supplementary material).
The hexaﬂuorophosphate anion interacts with C6H6 ligand through
C–H  F contacts: the C  F distances being 3.22 and 3.26 Å with C–
H  F angles of 148.9 and 138.3, respectively. In addition to this
the oxygen atom interacts with one of the hydrogen atoms of li-
gand L1through C–H  O contact: the C  O distance being 3.10 Å
and C–H  O angle is 149.06.
3.4. Characterization of the dinuclear complexes
The infrared spectra of the dinuclear complexes [13](PF6)2 –
[24](PF6)2 exhibit a similar trend as for the mononuclear com-
plexes [1]PF6 – [12]PF6. The mass spectra of these complexes
exhibited two main peaks; a minor peak with an approximately
50% intensity attributed to [MPF6]+ at m/z 786, 814, 842, 898,
926, 954, 904, 932, 960, 1082, 1110 and 1138, respectively, and a
major peak which corresponds to the loss of an [(arene/Cp*)MCl]+
fragment, thus giving the corresponding mononuclear cations
[1PF6]+ – [12PF6]+ at m/z = 427, 455, 483, 483, 511, 538, 485,
513, 541, 575, 603 and 631.
The 1H NMR spectra of the dinuclear complexes [13](PF6)2 –
[24](PF6)2, exhibit ﬁve distinct resonances, which are assigned to
pyrazole or substituted pyrazoles and pyrimidine ring protons of
the ligand L1 or L2 or L3, indicating the formation of dinuclear
complexes. The number of distinct resonances of these complexes
is similar to the number of distinct resonances of free ligands, indi-
cating that the pyrazole rings of the ligands remain symmetrical
even after formation of the complexes. These results indicate the
formation of dinuclear complexes. The resonances of the coordi-
nated pyrazole and pyrimidine protons shifted to considerable
down ﬁled as compared to mononuclear complexes, a consequence
of their coordination to two ruthenium, rhodium or iridium atoms.
However, in the arene ruthenium complexes [13](PF6)2 –
[18](PF6)2, the resonances of the ligand protons signiﬁcantly
shifted to down ﬁeld compared to Cp*Rh or Ir complexes,
[19](PF6)2 – [24](PF6)2. Besides these resonances complexes
Fig. 3. Molecular structure of [7]PF6 at 50% probability level. Hydrogen atoms and
anion have been omitted for clarity.
Fig. 4. Molecular structure of [18](PF6)2H2O at 50% probability level. Hydrogen atoms, water molecule and hexaﬂuorophosphate anions have been omitted for clarity.
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[13](PF6)2 – [15](PF6)2 exhibit a singlet for both benzene ring pro-
tons at d = 6.24 and 6.15 ppm, complexes [16](PF6)2 – [18](PF6)2
exhibit a similar trend like the mononuclear complexes [4]PF6 –
[4]PF6. A septet at d = 2.70 for the protons of the isopropyl group,
a singlet at d = 2.17 for the methyl protons of p-cymene ring, four
doublets ca. d = 6.09–5.93 for the ring protons of the p-cymene li-
gand and ﬁnally methyl protons of the isopropyl group displays
two doublets at ca. d = 1.18 and 1.07. Complexes [19](PF6)2 –
[24](PF6)2 exhibit a singlet in the region d = 1.88–1.77 for the ﬁve
methyl groups of the Cp* ligand. The chemical shift of the arene
co-ligands or Cp* ring protons are shifted to higher frequency
compared to the starting precursors as well as compared to the
mononuclear complexes.
3.5. Molecular structure of the dinuclear complex [18](PF6)2
The molecular structure of [{(g6-p-PriC6H4Me)RuCl}2(L3)]2+
([18](PF6)2) has been established by single crystal X-ray structure
analysis. Selected bond lengths and angles are presented in Table
2. The dinuclear complex [18](PF6)2 shows a typical piano-stool
geometry for the ruthenium atoms with the metal centers being
coordinated by the aromatic ligand, a terminal chloride and a che-
lating N,N-ligand (Fig. 4). The compound [18](PF6)2 contains two
Ru(II) metal centers which are bonded to a g6-p-PriC6H4Me ligand
and bridged by the L3 ligand through its nitrogen atoms. Interest-
ingly, the dinuclear complex [18](PF6)2 reveals a trans conforma-
tion of the two chloro ligands (Fig. 4). The distance between the
ruthenium atoms and the corresponding centroid of the g6-
p-iPrC6H4Me ring is 1.68 and 1.67 Å. These distances are compara-
ble to those in the related complex cation [(g6-p-iPrC6H4Me)Ru
(2-acetylthiazoleazine)Cl]+ [60].
The Ru–N bond distances ranging from 2.072(3) to 2.092(3) Å
are shorter than in the mononuclear complex [6]PF6 [2.102(3)
and 2.093(3) Å], interestingly the Ru to N1 or N5 (pyrazole) dis-
tances are shorter than the Ru–N3 or N6 (pyrimidine) distances
in the dinuclear complex [18](PF6)2, where as it is opposite in
mononuclear complex [6]PF6, while the ruthenium–chlorine bond
distances are comparable. In complex [18](PF6)2, the isopropyl
group of the p-cymene ligand at Ru1 center located opposite to
the halide ligand in order to reduce steric interactions, while at
Ru2 the isopropyl group is located on same side to the halide
ligand.
Complex [18](PF6)2 crystallizes with one molecule of water per
asymmetric unit, forming an hydrogen-bonded network to the
chloride atom and the ﬂuorine atom of the hexaﬂuorophosphate
anion (Fig. 5). The water molecule interacts with chloride ligand
through O–H  Cl contacts: the O  Cl distance being 3.26 Å with
an O–H  Cl angle of 156.3. In addition to this, the water molecule
interacts with one of the ﬂuoride atoms of the hexaﬂuorophos-
phate anion through F  H–O contacts: the F  O distance being
3.51 Å and the F  H–O angle 154.09.
4. UV–Vis spectroscopy
Electronic absorption spectra of the mononuclear complexes
[1]PF6 – [12]PF6 as well as the dinuclear complexes [13](PF6)2 –
[24](PF6)2 were acquired in acetonitrile, at 105 M concentration
in the range 250–550 nm. Electronic spectra of representative
complexes are depicted in Fig. 6. The spectra of these complexes
are characterized by two main features, viz., an intense ligand–
localized or intra-ligand p? p* transition in the ultraviolet region
and metal-to-ligand charge transfer (MLCT) dp(M) ? p* (L1 – li-
gand) bands in the visible region [61]. Since the low spin d6 conﬁg-
uration of the mononuclear complexes provides ﬁlled orbitals of
suitable symmetry at the Ru(II), Rh(III) and Ir(III) centers, these
can interact with low lying p* orbitals of the ligands. All these
mononuclear complexes [1]PF6 – [12]PF6 show two medium inten-
sity bands in the region 261–310 nm, an intense band in the region
340–380 nm in UV region and a low energy absorption band in the
visible region 450–470 nm. Where as the dinuclear complexes
[13](PF6)2 – [24](PF6)2 shown similar number of bands in higher
frequency region, for instance a medium intensity band in the re-
gion 260–275 nm, a high intensity band in the region 318–
322 nm and a broad band in the region 356–418 nm. The medium
intensity bands in UV region is assigned to p–p*, a high intensity
band in UV region is assigned to inter and intra-ligand p–p*/n –
p* transitions [62,63], while the low energy absorption band in
the visible region is assigned to metal-to-ligand charge transfer
(MLCT) (t2g–p*).
Fig. 5. Hydrogen bond network in [18](PF6)2H2O showing the intermolecular
interactions involving an hexaﬂuorophosphate anion, a water molecule and cation
[18]+. Fig. 6. UV–Vis electronic spectra of selected complexes in acetonitrile at 298 K.
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5. Conclusions
We have described and characterized new mono and dinuclear
ruthenium, rhodium and iridium complexes with the ligands L1, L2
and L3, in good yield, which are remarkably stable in air as well as
in solution. In both, mono and dinuclear complexes, the metal
atom are bonded with the N-atom of the pyrazole moiety and
the N-atom of the pyrimidine moiety. But our effort to make het-
ero-nuclear complexes by using second binding site of the mono-
nuclear complexes was unsuccessful, since coordination of the
ﬁrst metallic center does not induce the bonding in the second po-
sition in a kind of chemical symbiosis driven by the ligand or the
metal center.
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